Результаты исследований: Рабочие материалы › Препринт
Amino acid profiling of COVID-19 patients blood serum. / Русских, Я.В.; Сушенцева, Наталья Николаевна; Попов, Олег Сергеевич; Апалько, Светлана Вячеславовна; Шиманский, Валентин Сергеевич; Асиновская, Анна Юрьевна; Мосенко, Сергей Викторович; Сарана, Андрей Михайлович; Щербак, Сергей Григорьевич.
BMJ Publishing Group, 2024.Результаты исследований: Рабочие материалы › Препринт
}
TY - UNPB
T1 - Amino acid profiling of COVID-19 patients blood serum
AU - Русских, Я.В.
AU - Сушенцева, Наталья Николаевна
AU - Попов, Олег Сергеевич
AU - Апалько, Светлана Вячеславовна
AU - Шиманский, Валентин Сергеевич
AU - Асиновская, Анна Юрьевна
AU - Мосенко, Сергей Викторович
AU - Сарана, Андрей Михайлович
AU - Щербак, Сергей Григорьевич
PY - 2024/3/6
Y1 - 2024/3/6
N2 - Main objectives of this study were to analyse metabolomic profile features of patients with COVID-19 using mass spectrometry techniques while taking into account the clinical and laboratory history, and to study the relationship between the severity of COVID-19 symptoms and the concentration of primary metabolites, primarily amino acids. We used frozen blood serum samples of 935 COVID-19 patients from the City Hospital No. 40 biobank collection. Metabolomic profile was studied by HPLS-MS/MS method. R programming language was used for statistical data processing. The difference of metabolic profile of patients with COVID-19 depending on the severity of the disease was revealed based on the performed analysis - for 52 out of 84 detected compounds there were differences with reliability p<0,01. Statistically significant differences in concentration were recorded for organic acids, amino acids and their derivatives. Using samples from the biobank collection, a metabolomic study of the biomaterial of patients hospitalised with the diagnosis of COVID-19 was carried out. According to the results obtained, kynurenine, phenylalanine and acetylcarnitine were associated with the severity of COVID-19 infection.
AB - Main objectives of this study were to analyse metabolomic profile features of patients with COVID-19 using mass spectrometry techniques while taking into account the clinical and laboratory history, and to study the relationship between the severity of COVID-19 symptoms and the concentration of primary metabolites, primarily amino acids. We used frozen blood serum samples of 935 COVID-19 patients from the City Hospital No. 40 biobank collection. Metabolomic profile was studied by HPLS-MS/MS method. R programming language was used for statistical data processing. The difference of metabolic profile of patients with COVID-19 depending on the severity of the disease was revealed based on the performed analysis - for 52 out of 84 detected compounds there were differences with reliability p<0,01. Statistically significant differences in concentration were recorded for organic acids, amino acids and their derivatives. Using samples from the biobank collection, a metabolomic study of the biomaterial of patients hospitalised with the diagnosis of COVID-19 was carried out. According to the results obtained, kynurenine, phenylalanine and acetylcarnitine were associated with the severity of COVID-19 infection.
KW - infectious diseases
U2 - 10.1101/2024.03.05.24303773
DO - 10.1101/2024.03.05.24303773
M3 - Препринт
BT - Amino acid profiling of COVID-19 patients blood serum
PB - BMJ Publishing Group
ER -
ID: 120029259